Check out this article featuring Dr. Whitney Jones, the Project's founder. As a high-risk individual, I found this really helpful when considering whether an aspirin regimine is right for me.
An interesting outtake:
"Now comes news that colon cancer patients who begin, or continue, a low-dose aspirin regime after diagnosis showed a 30 percent lower risk of death compared to non-users.
So why isn't every one popping a daily aspirin?
The studies are very compelling, says Whitney Jones, MD, Clinical Professor of Medicine at University of Louisville and founder of the Colon Cancer Prevention Project, "but they very clearly state the cornerstone continues to be intensive screening and preventative services, not just aspirin."
In other words, aspirin is not going to replace screening and prevention. And it may not be for everyone."